Jubilant Life Sciences has announced that it has received approval from the US Food and Drug Administration (FDA) for its anti-depressant drug Bupropion Hydrochloride.
"We have also received approval for the same extended drug used as smoking cessation aid. Both formulations are generic version of GlaxoSmithKline's Wellbutrin and Zyban tablets respectively," the company said in a statement here.
Depression
Depression is one of the most common mental disorders affecting approximately 340 million people in the world. No one is immune from depression - it occurs in people of all social classes, all countries and all cultural settings.
Advertisement
The market size for the twin products is estimated to be around $518 million annually.
"We propose to launch both the drugs in this quarter of 2013-14," the statement said.
The company has filed 649 applications for formulations till June, of which 189 were approved in different geographies the world over, including 58 abbreviated new drug application (ANDA) in the US and 41 dossier filings in Europe.
![Depression Symptom Evaluation]( "Depression Symptom Evaluation")
Depression occurs due to alterations in the levels of neurotransmitters in the brain.
With 10 production facilities across India, Canada and the US, Jubilant manufactures and supplies active pharmaceutical ingredients (APIs), generics, specialty pharmaceuticals and life science ingredients, besides providing services in contract manufacturing and drug discovery and development.
Source: IANS
The company has filed 649 applications for formulations till June, of which 189 were approved in different geographies the world over, including 58 abbreviated new drug application (ANDA) in the US and 41 dossier filings in Europe.
Depression Symptom Evaluation
Depression occurs due to alterations in the levels of neurotransmitters in the brain.
Advertisement
With 10 production facilities across India, Canada and the US, Jubilant manufactures and supplies active pharmaceutical ingredients (APIs), generics, specialty pharmaceuticals and life science ingredients, besides providing services in contract manufacturing and drug discovery and development.
Source: IANS
Holistic Management for Depression
Depression is a common disorder and many worldwide suffer from depression. Early recognition of symptoms and signs of depression can help in taking a holistic approach to the management of depression.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Lifestyle and Wellness News
The skin between the toes and behind the ears can harbor many harmful germs that can cause a variety of skin illnesses.
Prolonged sitting among office goers, pose risk of cardiovascular diseases, diabetes, hypertension, and certain types of cancers.
Yogurt's protein and fat content demonstrated its unidentified deodorizing properties against garlic's pungent odor.
People who smoke tobacco and cannabis have an increased risk of depression and anxiety than those who use either substance alone or not at all.
Research reveals the association between cognitive impairment and physically demanding careers, emphasizing the need for preventative strategies.
